2026. Nuclear-Targeted Engineering of a Lunasin-Derived Peptide Enhances Antiproliferative Activity and AP-1-Associated Gene Modulation in A549 Lung Cancer Cells. Al Mustansiriyah Journal of Pharmaceutical Sciences. 26, 3 (Sep. 2026), 331–353. DOI:https://doi.org/10.32947/ajps.v26i3.1404.